Bajaj Steel Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:50 pm

Quick Insight

Bajaj Steel Industries Ltd, an engineering-heavy company, currently trades at a price of 513 with a market capitalization of 1,067 Cr. The stock has a P/E ratio of 18.8, indicating a reasonable valuation, while boasting a solid ROE of 17.9% and ROCE of 21.3%. The operating profit margin stands at 12.60%, reflecting operational efficiency. With healthy reserves of 377 Cr and manageable borrowings of ₹65 Cr, the company's financial position appears stable. However, the high CCC of 135 days warrants attention for potential working capital management improvements. Overall, investors may find value in this fundamentally sound company, but monitoring working capital closely is advised for sustained growth.

Competitors of Bajaj Steel Industries Ltd

All Competitor Stocks of Bajaj Steel Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:45 am

Below is a detailed analysis of the quarterly data for Bajaj Steel Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 107.53 Cr.. The value appears to be declining and may need further review. It has decreased from 153.50 Cr. (Mar 2025) to 107.53 Cr., marking a decrease of 45.97 Cr..
• For Expenses, as of Jun 2025, the value is 93.98 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 129.32 Cr. (Mar 2025) to 93.98 Cr., marking a decrease of 35.34 Cr..
• For Operating Profit, as of Jun 2025, the value is 13.55 Cr.. The value appears to be declining and may need further review. It has decreased from 24.18 Cr. (Mar 2025) to 13.55 Cr., marking a decrease of 10.63 Cr..
• For OPM %, as of Jun 2025, the value is 12.60%. The value appears to be declining and may need further review. It has decreased from 15.75% (Mar 2025) to 12.60%, marking a decrease of 3.15%.
• For Other Income, as of Jun 2025, the value is 1.40 Cr.. The value appears to be declining and may need further review. It has decreased from 6.49 Cr. (Mar 2025) to 1.40 Cr., marking a decrease of 5.09 Cr..
• For Interest, as of Jun 2025, the value is 1.29 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.39 Cr. (Mar 2025) to 1.29 Cr., marking a decrease of 0.10 Cr..
• For Depreciation, as of Jun 2025, the value is 3.73 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.03 Cr. (Mar 2025) to 3.73 Cr., marking a decrease of 2.30 Cr..
• For Profit before tax, as of Jun 2025, the value is 9.93 Cr.. The value appears to be declining and may need further review. It has decreased from 23.25 Cr. (Mar 2025) to 9.93 Cr., marking a decrease of 13.32 Cr..
• For Tax %, as of Jun 2025, the value is 25.48%. The value appears to be increasing, which may not be favorable. It has increased from 22.37% (Mar 2025) to 25.48%, marking an increase of 3.11%.
• For Net Profit, as of Jun 2025, the value is 7.40 Cr.. The value appears to be declining and may need further review. It has decreased from 18.06 Cr. (Mar 2025) to 7.40 Cr., marking a decrease of 10.66 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.56. The value appears to be declining and may need further review. It has decreased from 8.68 (Mar 2025) to 3.56, marking a decrease of 5.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:40 pm

Balance Sheet

Last Updated: July 25, 2025, 1:45 pm

Below is a detailed analysis of the balance sheet data for Bajaj Steel Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 7.00 Cr..
• For Reserves, as of Mar 2025, the value is 377.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2024) to 377.00 Cr., marking an increase of 47.00 Cr..
• For Borrowings, as of Mar 2025, the value is 65.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 64.00 Cr. (Mar 2024) to 65.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 151.00 Cr.. The value appears to be improving (decreasing). It has decreased from 168.00 Cr. (Mar 2024) to 151.00 Cr., marking a decrease of 17.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 604.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 563.00 Cr. (Mar 2024) to 604.00 Cr., marking an increase of 41.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 175.00 Cr.. The value appears to be declining and may need further review. It has decreased from 185.00 Cr. (Mar 2024) to 175.00 Cr., marking a decrease of 10.00 Cr..
• For CWIP, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 13.00 Cr..
• For Other Assets, as of Mar 2025, the value is 400.00 Cr.. The value appears strong and on an upward trend. It has increased from 346.00 Cr. (Mar 2024) to 400.00 Cr., marking an increase of 54.00 Cr..
• For Total Assets, as of Mar 2025, the value is 604.00 Cr.. The value appears strong and on an upward trend. It has increased from 563.00 Cr. (Mar 2024) to 604.00 Cr., marking an increase of 41.00 Cr..

Notably, the Reserves (377.00 Cr.) exceed the Borrowings (65.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Bajaj Steel Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 40.27. This value is within the healthy range. It has decreased from 113.75 (Mar 24) to 40.27, marking a decrease of 73.48.
• For Diluted EPS (Rs.), as of Mar 25, the value is 40.27. This value is within the healthy range. It has decreased from 113.75 (Mar 24) to 40.27, marking a decrease of 73.48.
• For Cash EPS (Rs.), as of Mar 25, the value is 47.73. This value is within the healthy range. It has decreased from 136.37 (Mar 24) to 47.73, marking a decrease of 88.64.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 186.26. It has decreased from 638.72 (Mar 24) to 186.26, marking a decrease of 452.46.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 186.26. It has decreased from 638.72 (Mar 24) to 186.26, marking a decrease of 452.46.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 281.15. It has decreased from 1,059.54 (Mar 24) to 281.15, marking a decrease of 778.39.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 50.26. This value is within the healthy range. It has decreased from 184.90 (Mar 24) to 50.26, marking a decrease of 134.64.
• For PBIT / Share (Rs.), as of Mar 25, the value is 43.08. This value is within the healthy range. It has decreased from 162.02 (Mar 24) to 43.08, marking a decrease of 118.94.
• For PBT / Share (Rs.), as of Mar 25, the value is 53.81. This value is within the healthy range. It has decreased from 153.09 (Mar 24) to 53.81, marking a decrease of 99.28.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 40.55. This value is within the healthy range. It has decreased from 113.49 (Mar 24) to 40.55, marking a decrease of 72.94.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 40.55. This value is within the healthy range. It has decreased from 113.49 (Mar 24) to 40.55, marking a decrease of 72.94.
• For PBDIT Margin (%), as of Mar 25, the value is 17.87. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 17.87, marking an increase of 0.42.
• For PBIT Margin (%), as of Mar 25, the value is 15.32. This value is within the healthy range. It has increased from 15.29 (Mar 24) to 15.32, marking an increase of 0.03.
• For PBT Margin (%), as of Mar 25, the value is 19.14. This value is within the healthy range. It has increased from 14.44 (Mar 24) to 19.14, marking an increase of 4.70.
• For Net Profit Margin (%), as of Mar 25, the value is 14.42. This value exceeds the healthy maximum of 10. It has increased from 10.71 (Mar 24) to 14.42, marking an increase of 3.71.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 10.71 (Mar 24) to 14.42, marking an increase of 3.71.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.76. This value is within the healthy range. It has increased from 17.76 (Mar 24) to 21.76, marking an increase of 4.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.27. This value is within the healthy range. It has decreased from 23.31 (Mar 24) to 21.27, marking a decrease of 2.04.
• For Return On Assets (%), as of Mar 25, the value is 13.97. This value is within the healthy range. It has increased from 10.47 (Mar 24) to 13.97, marking an increase of 3.50.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has decreased from 0.16 (Mar 24) to 0.15, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.00. It has decreased from 1.09 (Mar 24) to 1.00, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.97. This value is within the healthy range. It has increased from 1.77 (Mar 24) to 1.97, marking an increase of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has increased from 1.07 (Mar 24) to 1.13, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 4. It has decreased from 2.29 (Mar 24) to 2.01, marking a decrease of 0.28.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.64 (Mar 24) to 0.00, marking a decrease of 2.64.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.19 (Mar 24) to 0.00, marking a decrease of 2.19.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.36 (Mar 24) to 0.00, marking a decrease of 97.36.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.81 (Mar 24) to 0.00, marking a decrease of 97.81.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 24.96. This value is within the healthy range. It has increased from 20.70 (Mar 24) to 24.96, marking an increase of 4.26.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.80. This value is within the healthy range. It has increased from 13.70 (Mar 24) to 14.80, marking an increase of 1.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,452.01. It has increased from 565.77 (Mar 24) to 1,452.01, marking an increase of 886.24.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 2.48, marking an increase of 1.45.
• For EV / EBITDA (X), as of Mar 25, the value is 13.89. This value is within the healthy range. It has increased from 5.88 (Mar 24) to 13.89, marking an increase of 8.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.52. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 2.52, marking an increase of 1.43.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 97.35 (Mar 24) to 0.00, marking a decrease of 97.35.
• For Price / BV (X), as of Mar 25, the value is 3.80. This value exceeds the healthy maximum of 3. It has increased from 1.80 (Mar 24) to 3.80, marking an increase of 2.00.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.52. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 2.52, marking an increase of 1.43.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness